The U.S. Food and Drug Administration will host a town hall to discuss its final guidance on the use of real-world evidence (RWE) to support regulatory decision-making for medical devices. TThe session will review expanded and updated recommendations for sponsors and FDA staff considering RWE in regulatory submissions.